Kiriazopoulou Venetsana

Kiriazopoulou Venetsana Endocrinologist

Education & Academic Qualifications

  • University: University Medical School   Parma –Italy, Thessaloniki Univ Medical School, Greece
  • Residency: Patras University Medical School, Dpt of Medicine
  • Fellowship: Medicine: Patras University Medical School, Dpt of Medicine, Patras, Greece
  • Department of Endocrinology and Metabolism

Work Experience

  • EM.Professor , Patras Univercity Medical School  Greece


  • 1990: Endocrinology and Metabolism

EDUCATION—TEACHING  still now as EM. Professor

  • 1st – 6th year medical students, Patras Medical School

  • 4 th year medical students, Patras Medical School in Endocrinology and Metabolism

  • 1st – 4th year Fellows in Endocrinology


  • scientific reviewer for several medical journals, as BMJ, Expert   Opinion on Pharmacotherapy  , Annals of Nutrition and Metabolism, Expert Review of Endocrinology & Metabolism, The Endocrine Society journals of America etc.)


  • 4 post-doc fellows working on HPA AXIS and metabolic syndrome,obesity   and sepsis projects

  • 19 PhD fellows graduated working on projects of my research interest



  • Head Consultant in Endocrinology in Internal Medicine Department 2010-2020

  • Member of Division of Endocrinology and Metabolism of Internal Medicine Department since 1983

  • Head  of the Diabetic Center in Internal Medicine since 2000

  • Head of the Departement of Endocrinologr since 8/2020

  • Membership of undergraduate Committee2009 -8/2020

  • Membership of postgraduate Committee2009 –2020    

Research interests

  • Hypothalamic –Pituitary –Adrenal axis in health and disease

  • Diabetes and Metabolic disease

  • Thyroid disease, parathyroid disease


Citations- 3.840,(citations) H-index=28 (Scholar Google)

i I0-index 43


  • Dionysios Chartoumpekis, Athanasios Niarchos, Christina Petropoulou, Panagiota Batzali, Venetsana Kyriazopoulou, Ioannis Habeos|

    J Endocr Soc. 2019 Apr 15; 3(Suppl 1): SUN-048. Published online 2019 Apr 30. doi: 10.1210/js.2019-SUN-048, SUN-048 Matersitenal Caloric Restriction during Pregnancy Activates the Nrf2 Antioxidant Program in Embryonic Mouse Liver.

  • Triantos C, Kalafateli M, Aggeletopoulou I, Diamantopoulou G, Spantidea PI, Michalaki M, Vourli G, Konstantakis C, Assimakopoulos SF, Manolakopoulos S, Gogos C, Kyriazopoulou V, Mouzaki A, Thomopoulos K. Vitamin D-related immunomodulation in patients with liver cirrhosis.Eur J Gastroenterol Hepatol. 2020 Jul

  • Georgakopoulos-Soares I, Chartoumpekis DV, Kyriazopoulou V, Zaravinos A., EMT Factors and Metabolic Pathways in Cancer . Front Oncol. 2020 Apr 7; 10:499, review

  • Dionysios V Chartoumpekis, MD, PhD,1 Panos Ziros, PhD,2 Ioannis Habeos, MD, PhD,1 Venetsana Kyriazopoulou, MD, PhD,1 Adam Smith, PhD,3 Ana Claudia Marques, PhD,3 and Gerasimos P Sykiotis, MD, PhD. J Endocr Soc. 2020 May 8; 4(Suppl 1): SAT-445 Published online 2020 May 8 SAT-455 Mouse Thyroid Responds to Iodine Overload by Transcriptionally Enhancing the Keap1/Nrf2 Antioxidant Response and by Upregulating Nrf2-Dependent and Independent Inflammatory and Fibrosis Pathways

  • Georgios K. Markantes, Stylianos Tsochatzis, Konstantinos Panagopoulos, Maria Melachrinou, Venetsana E. Kyriazopoulou, Kostas B. Markou, Marina A. MichalakiLaryngoscope Investig Otolaryngol. 2020 Dec; 5(6): 1260–1265. Published online 2020

A shift to more targeted thyroidectomies increased the detection of thyroid cancer and in particular low‐risk papillary tumors in Southwestern Greece the decade 2007 to 2016

  • Delivanis DA, Iñiguez-Ariza NM, Zeb MH, Moynagh MR, Takahashi N, McKenzie TJ, Thomas MA, Gogos C, Young WF, Bancos I, Kyriazopoulou V. Impact of hypercortisolism on skeletal muscle mass and adipose tissue mass in patients with adrenal adenomas. Clin Endocrinol (Oxf). 2018 Feb;88(2):209-216. doi: 10.1111/cen.13512. Epub 2017 Nov 29

  • Constantinopoulos P, Michalaki M, Kottorou A, Habeos I, Psyrogiannis A, Kalfarentzos F, Kyriazopoulou V. Cortisol in tissue and systemic level as a contributing factor to the development of metabolic syndrome in severely obese patients. Eur J Endocrinol. 2015 Jan;172(1):69-78. doi: 10.1530/EJE-14-0626. Epub 2014 Oct 21

  • Sykiotis GP, Neumann S, Georgopoulos NA, Sgourou A, Papachatzopoulou A, Markou KB, Kyriazopoulou V, Paschke R, Vagenakis AG, Papavassiliou AG. Functional significance of the thyrotropin receptor germline polymorphism D727E. Biochem Biophys Res Commun. 2003 Feb 21; 301(4):1051-6 

  • Michalaki M, Vagenakis AG, Makri M, Kalfarentzos F, Kyriazopoulou V. Dissociation of the early decline in serum T (3) concentration and serum IL-6 rise and TNFalpha in nonthyroidal illness syndrome induced by abdominal surgery. J Clin Endocrinol Metab. 2001 Sep; 86(9):4198-205.

  • Markou K, Georgopoulos N, Kyriazopoulou V, Vagenakis AG. Iodine-Induced hypothyroidism. Thyroid. 2001 May;11(5):501-10.

  • Kyriazopoulou V, Vagenakis AG. Abnormal overnight dexamethasone suppression test in subjects receiving rifampicin therapy. J Clin Endocrinol Metab. 1992 Jul;75(1):315-7

  • Bassaris HP, Lianou PE, Mallioris KN, Skoutelis AT, Votta EG, Kyriazopoulou VE, Papavassiliou JT. Effects of methylprednisolone and dexamethasone on polymorphonuclear leukocyte adherence in vivo. Drugs Exp. Clin. Res. 1987; 13(5):267-71.

  • Venetsana Kyriazopoulou, Ourania Parparousi and Apostolos G. Vagenakis: Rifampicin-induced Adrenal Crisis in Adisοnian Patients Receiving Corticosteoid Replacement Therapy. Journal of Clinical Endocrinology and Metabolism vol. 59, No 6, 1984